Adames, Angela
O’Brien, Diana Roth
Kelly, Alison R.
Saltz, Leonard B.
Garcia-Aguilar, Julio
Zinovoy, Melissa
Williams, Vonetta
Wu, Abraham
Reyngold, Marsha
Hajj, Carla
Crane, Christopher
Cercek, Andrea
Smith, J. Joshua
Markova, Alina
Cuaron, John
McCann, Patrick
Romesser, Paul B.
Funding for this research was provided by:
National Institutes of Health (P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748)
Article History
Accepted: 8 May 2024
First Online: 23 May 2024
Ethics approval and consent to participate
: This retrospective analysis was approved by the institutional review board with a waiver of informed consent. Medical records were reviewed for patients with rectal adenocarcinoma who were treated with fluoropyrimidine-based chemoradiation from January 2021 through December 2023 at our institution.
: All patients provided written consent for publication of their clinical details and/or clinical images.
: Angela Adames serves on the Oncology Nursing Certification Corporation (ONCC) test development committee for the Oncology Certified Nurses (OCN<sup>®</sup>) examination, is this committee’s current chair, and receives travel and lodging support from ONCC outside of the submitted work. Leonard B. Saltz served as a consultant for Genor Biopharma Holdings Ltd. and Optimal Cancer Care Alliance (OCCA) and received research funding from Taiho Pharmaceutical outside of the submitted work. Julio Garcia-Aguilar has provided professional services to Ethicon and Intuitive Surgical Inc. outside of the submitted work. Andrea Cercek has received grants and contracts from GlaxoSmithKline and Seagen Inc. and has received honoraria from Bayer, GI Therapeutics, GlaxoSmithKline, Janssen Biotech, Merck, Pfizer Pharmaceuticals LLC, Roche, Amgen, Abbivie, and Seagen Inc. outside the submitted work. Christopher Crane serves as a consultant for TriSalus Life Siences. He has received research funding from Elekta outside of the submitted work. J. Joshua Smith received travel support for fellow education from Intuitive Surgical. He also served as a clinical advisor for Guardant Health as a clinical advisor for Foundation Medicine and as a consultant and speaker for Johnson and Johnson. He serves as a clinical advisor and consultant for GSK outside of the submitted work. Abraham Wu has provided consulting services to CivaTech Oncology, Inc., MORE Health, Inc., Nanovi A/S, and Simphotek, Inc. outside of the submitted work. Alina Markova has provided consulting services to ADC Therapeutics, Alira Health, AstraZeneca, Protagonist Therapeutics, OnQuality, and Janssen. She has also received research funding from Amryt Pharma, AstraZeneca, Incyte Corporation, Kintara Therapeutics, Novocure, and royalties from UptoDate outside of the submitted work. Paul B. Romesser received research funding and serves as a consultant for EMD Serono, receives research funding from XRAD Therapeutics, is a consultant for Faeth Therapeutics, is a consultant for Natera, and is a volunteer on the advisory board for the HPV Alliance and Anal Cancer Foundation non-profit organizations outside of the submitted work. All other authors have no conflicts of interest to declare.